The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Large, M. K.
Right arrow Articles by Hahn, Y. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Large, M. K.
Right arrow Articles by Hahn, Y. S.
The Journal of Immunology, 1999, 162: 931-938.
Copyright © 1999 by The American Association of Immunologists

Suppression of Host Immune Response by the Core Protein of Hepatitis C Virus: Possible Implications for Hepatitis C Virus Persistence1

Mary Kathryn Large*, David J. Kittlesen* and Young S. Hahn2,*,{dagger}

* Beirne Carter Center for Immunology Research and {dagger} Department of Pathology, University of Virginia, Charlottesville, VA 22908

Hepatitis C virus (HCV) is a major human pathogen causing mild to severe liver disease worldwide. This positive strand RNA virus is remarkably efficient at establishing chronic infections. Although a high rate of genetic variability may facilitate viral escape and persistence in the face of Ag-specific immune responses, HCV may also encode proteins that facilitate evasion of immunological surveillance. To address the latter possibility, we examined the influence of specific HCV gene products on the host immune response to vaccinia virus in a murine model. Various vaccinia/HCV recombinants expressing different regions of the HCV polyprotein were used for i.p. inoculation of BALB/c mice. Surprisingly, a recombinant expressing the N-terminal half of the polyprotein (including the structural proteins, p7, NS2, and a portion of NS3; vHCV-S) led to a dose-dependent increase in mortality. Increased mortality was not observed for a recombinant expressing the majority of the nonstructural region or for a negative control virus expressing the ß-galactosidase protein. Examination of T cell responses in these mice revealed a marked suppression of vaccinia-specific CTL responses and a depressed production of IFN-{gamma} and IL-2. By using a series of vaccinia/HCV recombinants, we found that the HCV core protein was sufficient for immunosuppression, prolonged viremia, and increased mortality. These results suggest that the HCV core protein plays an important role in the establishment and maintenance of HCV infection by suppressing host immune responses, in particular the generation of virus-specific CTLs.




This article has been cited by other articles:


Home page
J. Virol.Home page
P. Jagannathan, C. M. Osborne, C. Royce, M. M. Manion, J. C. Tilton, L. Li, S. Fischer, C. W. Hallahan, J. A. Metcalf, M. McLaughlin, et al.
Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness
J. Virol., March 15, 2009; 83(6): 2728 - 2742.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Lukens, M. W. Cruise, M. G. Lassen, and Y. S. Hahn
Blockade of PD-1/B7-H1 Interaction Restores Effector CD8+ T Cell Responses in a Hepatitis C Virus Core Murine Model
J. Immunol., April 1, 2008; 180(7): 4875 - 4884.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Dominguez-Villar, A. Munoz-Suano, B. Anaya-Baz, S. Aguilar, J. P. Novalbos, J. A. Giron, M. Rodriguez-Iglesias, and F. Garcia-Cozar
Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis
J. Leukoc. Biol., November 1, 2007; 82(5): 1301 - 1310.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. R. Ciccaglione, E. Stellacci, C. Marcantonio, V. Muto, M. Equestre, G. Marsili, M. Rapicetta, and A. Battistini
Repression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory Genes
J. Virol., January 1, 2007; 81(1): 202 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Budhu and X. W. Wang
The role of cytokines in hepatocellular carcinoma
J. Leukoc. Biol., December 1, 2006; 80(6): 1197 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Saito, K. Meyer, R. Warner, A. Basu, R. B. Ray, and R. Ray
Hepatitis C Virus Core Protein Inhibits Tumor Necrosis Factor Alpha-Mediated Apoptosis by a Protective Effect Involving Cellular FLICE Inhibitory Protein
J. Virol., May 1, 2006; 80(9): 4372 - 4379.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
W. Li, J. Li, D. L. J. Tyrrell, and B. Agrawal
Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities
J. Gen. Virol., January 1, 2006; 87(1): 61 - 72.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Q. Yao, S. N. Waggoner, M. W. Cruise, C. Hall, X. Xie, D. W. Oldach, and Y. S. Hahn
SOCS1 and SOCS3 Are Targeted by Hepatitis C Virus Core/gC1qR Ligation To Inhibit T-Cell Function
J. Virol., December 15, 2005; 79(24): 15417 - 15429.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. N. Waggoner, M. W. Cruise, R. Kassel, and Y. S. Hahn
gC1q Receptor Ligation Selectively Down-Regulates Human IL-12 Production through Activation of the Phosphoinositide 3-Kinase Pathway
J. Immunol., October 1, 2005; 175(7): 4706 - 4714.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. W. Cruise, H. M. Melief, J. Lukens, C. Soguero, and Y. S. Hahn
Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation
J. Leukoc. Biol., August 1, 2005; 78(2): 412 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Joo, Y. S. Hahn, M. Kwon, R. T. Sadikot, T. S. Blackwell, and J. W. Christman
Hepatitis C Virus Core Protein Suppresses NF-{kappa}B Activation and Cyclooxygenase-2 Expression by Direct Interaction with I{kappa}B Kinase {beta}
J. Virol., June 15, 2005; 79(12): 7648 - 7657.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Boni, J.-P. Lavergne, S. Boulant, and A. Cahour
Hepatitis C Virus Core Protein Acts as a trans-Modulating Factor on Internal Translation Initiation of the Viral RNA
J. Biol. Chem., May 6, 2005; 280(18): 17737 - 17748.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Sundstrom, S. Ota, L. Y. Dimberg, M. G. Masucci, and A. Bergqvist
Hepatitis C Virus Core Protein Induces an Anergic State Characterized by Decreased Interleukin-2 Production and Perturbation of Mitogen-Activated Protein Kinase Responses
J. Virol., February 15, 2005; 79(4): 2230 - 2239.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Li, T. Zhang, C. Ho, J. S. Orange, S. D. Douglas, and W.-Z. Ho
Natural killer cells inhibit hepatitis C virus expression
J. Leukoc. Biol., December 1, 2004; 76(6): 1171 - 1179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Eisen-Vandervelde, S. N. Waggoner, Z. Q. Yao, E. M. Cale, C. S. Hahn, and Y. S. Hahn
Hepatitis C Virus Core Selectively Suppresses Interleukin-12 Synthesis in Human Macrophages by Interfering with AP-1 Activation
J. Biol. Chem., October 15, 2004; 279(42): 43479 - 43486.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Q. Yao, A. Eisen-Vandervelde, S. N. Waggoner, E. M. Cale, and Y. S. Hahn
Direct Binding of Hepatitis C Virus Core to gC1qR on CD4+ and CD8+ T Cells Leads to Impaired Activation of Lck and Akt
J. Virol., June 15, 2004; 78(12): 6409 - 6419.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Maillard, J.-P. Lavergne, S. Siberil, G. Faure, F. Roohvand, S. Petres, J. L. Teillaud, and A. Budkowska
Fc{gamma} Receptor-like Activity of Hepatitis C Virus Core Protein
J. Biol. Chem., January 23, 2004; 279(4): 2430 - 2437.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J.-W. Youn, S.-H. Park, J. H. Cho, and Y. C. Sung
Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization
J. Virol., November 1, 2003; 77(21): 11596 - 11602.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Sarobe, J. J. Lasarte, A. Zabaleta, L. Arribillaga, A. Arina, I. Melero, F. Borras-Cuesta, and J. Prieto
Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses
J. Virol., October 15, 2003; 77(20): 10862 - 10871.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Herzer, C. S. Falk, J. Encke, S. T. Eichhorst, A. Ulsenheimer, B. Seliger, and P. H. Krammer
Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity
J. Virol., August 1, 2003; 77(15): 8299 - 8309.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Bergqvist, S. Sundstrom, L. Y. Dimberg, E. Gylfe, and M. G. Masucci
The Hepatitis C Virus Core Protein Modulates T Cell Responses by Inducing Spontaneous and Altering T-cell Receptor-triggered Ca2+ Oscillations
J. Biol. Chem., May 23, 2003; 278(21): 18877 - 18883.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Ning, S. Lakatoo, M. Liu, W. Yang, Z. Wang, M. J. Phillips, and G. A. Levy
Induction of Prothrombinase fgl2 by the Nucleocapsid Protein of Virulent Mouse Hepatitis Virus Is Dependent on Host Hepatic Nuclear Factor-4alpha
J. Biol. Chem., April 25, 2003; 278(18): 15541 - 15549.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Ni, E. Hembrador, A. M. Di Bisceglie, I. M. Jacobson, A. H. Talal, D. Butera, C. M. Rice, T. J. Chambers, and L. B. Dustin
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
J. Immunol., March 15, 2003; 170(6): 3429 - 3439.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Wedemeyer, X.-S. He, M. Nascimbeni, A. R. Davis, H. B. Greenberg, J. H. Hoofnagle, T. J. Liang, H. Alter, and B. Rehermann
Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection
J. Immunol., September 15, 2002; 169(6): 3447 - 3458.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mahalingam, J. Meanger, P. S. Foster, and B. A. Lidbury
The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses
J. Leukoc. Biol., September 1, 2002; 72(3): 429 - 439.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Soguero, M. Joo, K. A. Chianese-Bullock, D. T. Nguyen, K. Tung, and Y. S. Hahn
Hepatitis C Virus Core Protein Leads to Immune Suppression and Liver Damage in a Transgenic Murine Model
J. Virol., August 12, 2002; 76(18): 9345 - 9354.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Bichr, R. Rende-Fournier, G. Vona, A.-M. Yamamoto, E. Depla, G. Maertens, and C. Brechot
Detection of neutralizing antibodies to hepatitis C virus using a biliary cell infection model
J. Gen. Virol., June 1, 2002; 83(7): 1673 - 1678.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Varaklioti, N. Vassilaki, U. Georgopoulou, and P. Mavromara
Alternate Translation Occurs within the Core Coding Region of the Hepatitis C Viral Genome
J. Biol. Chem., May 10, 2002; 277(20): 17713 - 17721.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Sarobe, J. J. Lasarte, N. Casares, A. Lopez-Diaz de Cerio, E. Baixeras, P. Labarga, N. Garcia, F. Borras-Cuesta, and J. Prieto
Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins
J. Virol., April 16, 2002; 76(10): 5062 - 5070.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z.-X. Liu, H. Nishida, J.-W. He, M. M. C. Lai, N. Feng, and G. Dennert
Hepatitis C Virus Genotype 1b Core Protein Does Not Exert Immunomodulatory Effects on Virus-Induced Cellular Immunity
J. Virol., February 1, 2002; 76(3): 990 - 997.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. PERLEMUTER, A. SABILE, P. LETTERON, G. VONA, A. TOPILCO, Y. CHRETIEN, K. KOIKE, D. PESSAYRE, J. CHAPMAN, G. BARBA, et al.
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis
FASEB J, February 1, 2002; 16(2): 185 - 194.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C.-T. K. Tseng and G. R. Klimpel
Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions
J. Exp. Med., December 31, 2001; 195(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Sun, F. Bodola, X. Fan, H. Irshad, L. Soong, S. M. Lemon, and T.-S. Chan
Hepatitis C Virus Core and Envelope Proteins Do Not Suppress the Host's Ability To Clear a Hepatic Viral Infection
J. Virol., December 15, 2001; 75(24): 11992 - 11998.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Q. Yao, D. T. Nguyen, A. I. Hiotellis, and Y. S. Hahn
Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway
J. Immunol., November 1, 2001; 167(9): 5264 - 5272.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Maillard, K. Krawczynski, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, P. Gounon, J. Dubuisson, G. Faure, R. Crainic, and A. Budkowska
Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients
J. Virol., September 1, 2001; 75(17): 8240 - 8250.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Schweizer and E. Peterhans
Noncytopathic Bovine Viral Diarrhea Virus Inhibits Double-Stranded RNA-Induced Apoptosis and Interferon Synthesis
J. Virol., May 15, 2001; 75(10): 4692 - 4698.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. Bergqvist and C. M. Rice
Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein
J. Virol., January 15, 2001; 75(2): 772 - 781.
[Abstract] [Full Text]


Home page
J. Virol.Home page
T.-H. Wang, R. C. A. Rijnbrand, and S. M. Lemon
Core Protein-Coding Sequence, but Not Core Protein, Modulates the Efficiency of Cap-Independent Translation Directed by the Internal Ribosome Entry Site of Hepatitis C Virus
J. Virol., December 1, 2000; 74(23): 11347 - 11358.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
J. Matsumoto, S. Kawai, K. Terao, M. Kirinoki, Y. Yasutomi, M. Aikawa, and H. Matsuda
Malaria Infection Induces Rapid Elevation of the Soluble Fas Ligand Level in Serum and Subsequent T Lymphocytopenia: Possible Factors Responsible for the Differences in Susceptibility of Two Species of Macaca Monkeys to Plasmodium coatneyi Infection
Infect. Immun., March 1, 2000; 68(3): 1183 - 1188.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
T. J. Liang, B. Rehermann, L. B. Seeff, and J. H. Hoofnagle
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Ann Intern Med, February 15, 2000; 132(4): 296 - 305.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Arichi, T. Saito, M. E. Major, I. M. Belyakov, M. Shirai, V. H. Engelhard, S. M. Feinstone, and J. A. Berzofsky
Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model
PNAS, January 4, 2000; 97(1): 297 - 302.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Shimoike, S. Mimori, H. Tani, Y. Matsuura, and T. Miyamura
Interaction of Hepatitis C Virus Core Protein with Viral Sense RNA and Suppression of Its Translation
J. Virol., December 1, 1999; 73(12): 9718 - 9725.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.